Stocktwits on MSN
Quantum BioPharma Stock Rockets As Media Probe Shines Light On Spoofing Allegations Linked To Its $700M Lawsuit
The stock surged as Canadian media spotlight renewed scrutiny of Quantum’s alleged market-spoofing case. ・The coverage drew ...
The second of the three-part W5 investigative series can be viewed today on CTV News at: W5: Quantum BioPharma seeks $700M in stock spoofing lawsuit. Part 1 can be viewed at: W5: MS research derailed ...
Quantum BioPharma is at the center of a significant legal battle, alleging stock market manipulation by two major Canadian banks, CIBC and RBC, through a practice known as stock s ...
Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma”), is pleased to announce that national television network CTV News’ flagship investigative ...
Benitec Biopharma Inc. (NASDAQ: BNTC) is one of the best breakout stocks to invest in. On November 4, an analyst at Citizens ...
Just because a business does not make any money, does not mean that the stock will go down. By way of example, ...
Shares of Quantum BioPharma Ltd (NASDAQ:QNTM) are on watch Monday morning following a series of updates regarding its lead drug candidate for multiple sclerosis, Lucid-MS. Here’s what investors need ...
Vor Biopharma prices $100 million share offering as partner RemeGen reports strong Phase 3 results for telitacicept in IgA nephropathy.
On November 12, Scotiabank analyst Louise Chen began coverage on ten large-cap biopharma companies and shared an ...
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...
Ultragenyx and Mereo Biopharma, are expecting to report results from two phase 3 trials for Osteogenesis Imperfecta. Read ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback